HomeACADEMIA
ACADEMIA

Need for Resistance Testing a Factor in Selection of IFN-Free Therapies for Hep C: Hepatologist
(Nov.22.2016)

Dr Yatsuhashi
Hiroshi Yatsuhashi, head of Nagasaki Medical Center’s Clinical Research Center, said that doctors’ choices of interferon (IFN)-free therapies for chronic hepatitis C have been affected by whether or not testing for hepatitis C virus (HCV) drug resistance mutations prior to treatment is required ...
(LOG IN FOR FULL STORY)

News Calendar